Clinical Trials in Women's Health
If you have further questions, contact us at email email@example.com or call 916-734-6846.
- Contraceptive Clinical Trial for Healthy Women 16-40
UC Davis Obstetrics and Gynecology Research is conducting a contraceptive clinical trial looking at two intrauterine devices, one of which is investigational.
Pre-menopausal women ages 16-40 who are generally healthy, sexually active, at risk for pregnancy, and are not at risk for sexually transmitted infections may qualify.
Call the UC Davis Obstetrics and Gynecology Research number at 916-734-6846 or email us at firstname.lastname@example.org.
Financial compensation for time and travel may be provided.
- Hormonal Vaginal Ring Study
This clinical trial will study the efficacy, bleeding patterns, and safety of a new contraceptive vaginal ring over 12 months. The ring in this study is used for three months before it is changed.
- COMPARE Research Study
A nationwide study to help women and doctors better understand the effects of different treatments options for fibroids.
- Experiences and preferences of mothers of preterm infants in the Neonatal Intensive Care Unit (NICU)
We are looking to interview mothers of premature infants in the Neonatal Intensive Care Unit (NICU) about their experiences after delivery and how doctors can support their postpartum goals.
- A Study of the Effect of Probiotics on Gastrointestinal Function During Pregnancy
The purpose as well as the aim of this project is to understand the effect of probiotics on gastrointestinal (GI) dysfunction such as nausea, vomiting, and constipation that are found during the first and second trimesters of pregnancy
- Reproductive health outcomes by method of breast milk feeding
We are interested in understanding how breastmilk feeding affects bleeding after delivery.
- Study comparing diet and physical activity or usual care in improving length of survival without return of cancer
This study looks at whether changes in diet and physical activity can increase the length of survival without the return of cancer (progression-free survival) compared with usual care in patients with previously treated stage II, III, or IV ovarian, fallopian tube, or primary peritoneal cancer.
For more information about UC Davis Comprehensive Cancer Center Clinical Trials, click here